Economy

Dangerous delivery: how doctors in Geneva handled the hantavirus

This content was published on May 15, 2026 Geneva University Hospital was the first to identify the hantavirus variant behind an outbreak on a cruise ship in May 2026. Here’s how it did it.

Trump holds up executive order in favour of research and access to psychedelic treatments for mental health in the White House's Oval office.

New treatments

Good news for Switzerland: US is fast-tracking psychedelics for mental health

This content was published on May 11, 2026 Switzerland is the only country in Europe offering psychedelic treatments, but access remains extremely limited for patients. US support means things could change. An analysis by Swissinfo.

Health systems

Hundreds demonstrate in Zurich in support of chronic fatigue sufferers

This content was published on May 10, 2026 The organisers of the event are calling for improvements in diagnosis, medical care and research in this field.

Tampax tampon products on a supermarket shelf

Pharma supply chains

Major Swiss retailers face tampons shortage amid price negotiations

This content was published on May 9, 2026 Feminine hygiene products have been disappearing from Swiss supermarket shelves, as several retailers negotiate prices with American giant Procter & Gamble.

The acquisition is expected to increase the efficiency of laboratories

Swiss pharma firm Roche acquires AI specialist PathAI

This content was published on May 7, 2026 Roche agrees to acquire US company PathAI.

Do you trust AI with your health?

People are starting to use AI for health advice with mixed results. What has been your experience with AI for health information?

Join the discussion

May 7, 2026

3 Likes

7 Comments

View the discussion

Drug pricing

Truth or tale: can pharma companies set prices for new drugs as high as they want?

This content was published on May 6, 2026 Debates over drug pricing have prompted Swissinfo readers to ask whether pharma companies can set prices for new drugs as high as they want.

Novartis closes plant in Germany, 220 jobs away

Workplace

Novartis to close site in Germany and cut 220 jobs

This content was published on May 6, 2026 Swiss drugmaker Novartis plans to cut around 220 jobs in Germany as part of the planned closure of a production site in Wehr ⁠by the end of 2028.

Drug pricing

The drug-pricing problem no one wants to talk about

This content was published on May 4, 2026 Tackling the misuse of patents by some big pharma companies could go a long way to bringing down drug prices.

Agribusiness

Fertilisers should be a humanitarian commodity, says Keytrade boss

This content was published on May 2, 2026 Melih Keyman, CEO of the Swiss fertiliser trading firm Keytrade, warns that the war in Iran is pushing fertilisers out of reach for those who need them most.

Page 5 of 39

First … 3 4 5 6 7 … Last

Economy

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Economy

More

Dangerous delivery: how doctors in Geneva handled the hantavirus

More

Good news for Switzerland: US is fast-tracking psychedelics for mental health

More

Hundreds demonstrate in Zurich in support of chronic fatigue sufferers

More

Major Swiss retailers face tampons shortage amid price negotiations

More

Swiss pharma firm Roche acquires AI specialist PathAI

More

Do you trust AI with your health?

More

Truth or tale: can pharma companies set prices for new drugs as high as they want?

More

Novartis to close site in Germany and cut 220 jobs

More

The drug-pricing problem no one wants to talk about

More

Fertilisers should be a humanitarian commodity, says Keytrade boss

Popular Stories

Most Discussed